What is the initial workup for hematuria (presence of blood in urine) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Workup for Hematuria in Pregnancy

Ultrasound of the kidneys and bladder is the recommended first-line imaging for evaluation of hematuria in pregnancy, with more comprehensive workup deferred until after delivery once benign causes have been excluded. 1

Initial Assessment

  • Begin with thorough history, physical examination, urinalysis, and serologic testing before any imaging 1
  • Rule out common benign causes specific to pregnancy:
    • Urinary tract infection (obtain urine culture) 1, 2
    • Gynecologic bleeding (perform pelvic examination) 1, 3
    • Recent vigorous exercise 1
    • Viral illness 1

Epidemiology and Risk Assessment

  • The incidence of asymptomatic microhematuria in pregnant women is similar to non-pregnant women (approximately 20%) 1, 2
  • The risk of malignancy in pregnant women with hematuria is low 1
  • Dipstick hematuria is very common during pregnancy (20% in one study) but rarely indicates a condition that will impact pregnancy outcome 2

Diagnostic Algorithm

For Microhematuria in Pregnancy:

  1. Initial laboratory evaluation:

    • Complete urinalysis with microscopic examination 1
    • Urine culture to rule out infection 1, 2
    • Serum creatinine to assess renal function 2
    • Protein-to-creatinine ratio to evaluate for proteinuria 4
  2. First-line imaging:

    • Ultrasound of kidneys and bladder is the recommended initial imaging modality 1
    • Avoids radiation exposure to the fetus 1
    • Can identify most structural abnormalities of the urinary tract 1
  3. Additional imaging considerations:

    • MRU (magnetic resonance urography) without IV contrast may be reasonable in select cases 1
    • CT, CTU, and MRI with IV contrast should be avoided due to fetal radiation exposure or uncertain effects of gadolinium 1
    • Conventional radiographs, IVU (intravenous urography), and arteriography are not recommended 1

For Gross Hematuria in Pregnancy:

  • Requires more urgent evaluation due to higher association with malignancy (30-40% in general population) 1
  • Same initial workup as microhematuria, but with more expedited ultrasound 1
  • Consider urology consultation if no benign cause is identified 3, 5

Follow-up Recommendations

  • If benign cause identified (infection, gynecologic bleeding): treat appropriately and repeat urinalysis in 6 months 5
  • If no cause identified and initial evaluation is reassuring: defer comprehensive workup until after delivery 1
  • Postpartum follow-up is recommended as microscopic hematuria persists in approximately 50% of women after delivery 2

Important Caveats

  • Avoid unnecessary radiation exposure during pregnancy; ultrasound should be the first imaging modality 1
  • Avoid gadolinium-based contrast agents during pregnancy due to uncertain fetal effects 1
  • Dipstick testing alone is insufficient for diagnosis of hematuria and should be confirmed with microscopic examination 4
  • Consider the possibility of preeclampsia when hematuria is accompanied by hypertension, though isolated hematuria is not strongly associated with development of preeclampsia 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Microscopic hematuria in pregnancy: relevance to pregnancy outcome.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.